| A | B | C | |
|---|---|---|---|
| 1 | Main | ||
| 2 | Brand Name | INCB7839 | |
| 3 | Indication | Metastatic breast cancer | |
| 4 | Mechanism | Sheddase | |
| 5 | Administration | Oral | |
| 6 | Economics | NVS | |
| 7 | IP | ||
| 8 | |||
| 9 | Clinical Trials | ||
| 10 | Phase 2, n = 66 | ||
| 11 | No significant difference in PFS or reponse rate compared to historic data | ||
| 12 | Discontinued. |